Kambiz N. Alavian

Kambiz N. Alavian, PhD, SFHEA, FLS, FRSB, currently serves as a Reader in Neuroscience at Imperial College London since July 2013, where roles include Senior Lecturer and Principal Investigator. In addition to academic responsibilities, Kambiz N. Alavian is the Founding Director and CEO of GlioQuell since July 2022 and holds an adjunct associate professorship at Yale University School of Medicine. Editorial roles encompass Editor in Chief at Brain Disorders, and membership on editorial boards for several journals, including FASEB Journal and Translational Oncology. Kambiz N. Alavian's educational background includes a PhD in Neuroscience from Heidelberg University and various degrees from institutions such as the Illinois Institute of Technology and Imperial College London.